These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 29676250)

  • 41. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia.
    Maude RJ; Pontavornpinyo W; Saralamba S; Aguas R; Yeung S; Dondorp AM; Day NP; White NJ; White LJ
    Malar J; 2009 Feb; 8():31. PubMed ID: 19228438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border.
    Wongsrichanalai C; Meshnick SR
    Emerg Infect Dis; 2008 May; 14(5):716-9. PubMed ID: 18439351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
    Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM
    Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.
    Djimde AA; Makanga M; Kuhen K; Hamed K
    Expert Rev Anti Infect Ther; 2015 Aug; 13(8):1031-45. PubMed ID: 26081265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
    Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure.
    Witmer K; Dahalan FA; Delves MJ; Yahiya S; Watson OJ; Straschil U; Chiwcharoen D; Sornboon B; Pukrittayakamee S; Pearson RD; Howick VM; Lawniczak MKN; White NJ; Dondorp AM; Okell LC; Chotivanich K; Ruecker A; Baum J
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
    Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
    Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
    Barnes KI; White NJ
    Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.
    Zwang J; Dorsey G; Mårtensson A; d'Alessandro U; Ndiaye JL; Karema C; Djimde A; Brasseur P; Sirima SB; Olliaro P
    Malar J; 2014 Mar; 13():114. PubMed ID: 24666562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
    Nosten F; van Vugt M; Price R; Luxemburger C; Thway KL; Brockman A; McGready R; ter Kuile F; Looareesuwan S; White NJ
    Lancet; 2000 Jul; 356(9226):297-302. PubMed ID: 11071185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.
    Talisuna AO; Karema C; Ogutu B; Juma E; Logedi J; Nyandigisi A; Mulenga M; Mbacham WF; Roper C; Guerin PJ; D'Alessandro U; Snow RW
    Lancet Infect Dis; 2012 Nov; 12(11):888-96. PubMed ID: 23099083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
    Dini S; Zaloumis S; Cao P; Price RN; Fowkes FJI; van der Pluijm RW; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria.
    Dondorp AM; Smithuis FM; Woodrow C; Seidlein LV
    Trends Parasitol; 2017 May; 33(5):353-363. PubMed ID: 28187990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-nucleotide polymorphisms of artemisinin resistance-related pfubp1 and pfap2mu genes in imported Plasmodium falciparum to Wuhan, China.
    Cheng W; Wu K; Song X; Wang W; Du W; Li J
    Infect Genet Evol; 2022 Jul; 101():105286. PubMed ID: 35470127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions - India and sub-Saharan Africa.
    Arya A; Kojom Foko LP; Chaudhry S; Sharma A; Singh V
    Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():43-56. PubMed ID: 33556786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
    Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
    Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Elimination in South-East Asia? The role of antimalarial drugs].
    Nosten F
    Bull Acad Natl Med; 2016 Mar; 200(3):467-75; discussion 475-6. PubMed ID: 28644000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study.
    Taylor SM; Parobek CM; DeConti DK; Kayentao K; Coulibaly SO; Greenwood BM; Tagbor H; Williams J; Bojang K; Njie F; Desai M; Kariuki S; Gutman J; Mathanga DP; Mårtensson A; Ngasala B; Conrad MD; Rosenthal PJ; Tshefu AK; Moormann AM; Vulule JM; Doumbo OK; Ter Kuile FO; Meshnick SR; Bailey JA; Juliano JJ
    J Infect Dis; 2015 Mar; 211(5):680-8. PubMed ID: 25180240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination.
    Dhorda M; Amaratunga C; Dondorp AM
    Curr Opin Infect Dis; 2021 Oct; 34(5):432-439. PubMed ID: 34267045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport.
    Calçada C; Silva M; Baptista V; Thathy V; Silva-Pedrosa R; Granja D; Ferreira PE; Gil JP; Fidock DA; Veiga MI
    mBio; 2020 Dec; 11(6):. PubMed ID: 33262257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.